2 hours ago
Shay Martin announced that she has remarried about one year after her husband Tanner Martin's death from stage 4 colon cancer
The influencer emphasized in an Instagram video that "moving forward is not the same as moving on"
She tells PEOPLE in an exclusive statement that "love does not erase love"
Shay Martin has found love again.
The influencer announced in an Instagram video on Sunday, Aug. 2, that she has remarried following the death of her husband Tanner Martin from stage 4 colon cancer in June 2025.
#husband #stage
The influencer emphasized in an Instagram video that "moving forward is not the same as moving on"
She tells PEOPLE in an exclusive statement that "love does not erase love"
Shay Martin has found love again.
The influencer announced in an Instagram video on Sunday, Aug. 2, that she has remarried following the death of her husband Tanner Martin from stage 4 colon cancer in June 2025.
#husband #stage
3 hours ago
James Van Der Beek's wife, Kimberly, paid tribute to the late actor on what would have been their 16th anniversary
"The beauty of this marriage continues to unfold everyday with all these incredible children we have," she wrote alongside a photo of James hugging all six of their children
The Dawson's Creek alum was diagnosed with stage 3 colorectal cancer and died at 48 on Wednesday, Feb. 11
James Van Der Beek's wife, Kimberly, is remembering the late actor on what would have been their 16th anniversary.
On the couple's first wedding anniversary since James died at age 48 following a journey with stage 3 colorectal cancer in February, Kimberly, 44, expressed that, 16 years ago, she was "the luckiest woman in the world to marry vanderjames."
#kimberly #anniversary #actor #cancer
"The beauty of this marriage continues to unfold everyday with all these incredible children we have," she wrote alongside a photo of James hugging all six of their children
The Dawson's Creek alum was diagnosed with stage 3 colorectal cancer and died at 48 on Wednesday, Feb. 11
James Van Der Beek's wife, Kimberly, is remembering the late actor on what would have been their 16th anniversary.
On the couple's first wedding anniversary since James died at age 48 following a journey with stage 3 colorectal cancer in February, Kimberly, 44, expressed that, 16 years ago, she was "the luckiest woman in the world to marry vanderjames."
#kimberly #anniversary #actor #cancer
3 hours ago
Originally appeared on E! Online
James Van Der Beek's wife Kimberly Van Der Beek is marking a special milestone in the pair's marriage.
Six months after the Dawson's Creek alum died following a yearslong battle with colorectal cancer, his wife shared a message in honor of what would have been the couple's 16th wedding anniversary.
"16 years ago I was the luckiest woman in the world to marry vanderjames," Kimberly wrote on Instagram Aug. 1 alongside photos with the late actor. "The beauty of this marriage continues to unfold everyday with all these incredible children we have."
Indeed, Kimberly—mom to Olivia, 15, Joshua, 14, Annabel, 12, Emilia, 10, Gwendolyn, 8, and Jeremiah, 4, with James—shared she still feels her husband's presence, adding, "He continues to be present and guide us. I'm eternally grateful."
#originally
James Van Der Beek's wife Kimberly Van Der Beek is marking a special milestone in the pair's marriage.
Six months after the Dawson's Creek alum died following a yearslong battle with colorectal cancer, his wife shared a message in honor of what would have been the couple's 16th wedding anniversary.
"16 years ago I was the luckiest woman in the world to marry vanderjames," Kimberly wrote on Instagram Aug. 1 alongside photos with the late actor. "The beauty of this marriage continues to unfold everyday with all these incredible children we have."
Indeed, Kimberly—mom to Olivia, 15, Joshua, 14, Annabel, 12, Emilia, 10, Gwendolyn, 8, and Jeremiah, 4, with James—shared she still feels her husband's presence, adding, "He continues to be present and guide us. I'm eternally grateful."
#originally
10 hours ago
Bristol Myers Squibb (NYSE: BMY) looks attractive from a value perspective. For example, its dividend yield is a lofty 4% compared to the S&P 500 index's (SNPINDEX: ^GSPC) 1% and the pharmaceutical sector's average of around 1.5%. From a more traditional perspective, Bristol Myers Squibb's 17.5x price-to-earnings ratio is well below the industry average of 25x. Here's why it may not be as cheap as it looks and what needs to happen to change that.
There is nothing particularly unusual happening with Bristol Myers Squibb's business. That is important to highlight because the pharmaceutical industry is highly competitive, research-driven, and has a unique patent situation that materially complicates things even for the largest drug makers. The issue is that the patent protections for new drugs are time-limited, but research and development outcomes are unpredictable.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
That's the crux of the problem with Bristol Myers Squibb right now. Material patent expirations are occurring, including Revlimid and Pomalyst in 2026. And that will be followed by Eliquis, which is marketed with Pfizer (NYSE: PFE) in 2028. While patent expirations are common, the outcome is usually a material drop in revenue from the affected drugs. So Bristol Myers Squibb's top and bottom lines are going to be under pressure for a bit. If that's the case, the low P/E and high yield relative to the broader sector could simply be Wall Street pricing in the patent expirations.
Management isn't sitting around with its head in the sand. The company is actively looking for new drug candidates. And it actually has some attractive pipeline options in rare diseases, immunology, and cancer. If the company gets a couple of new blockbuster drugs approved, it could easily offset the hit from drugs that are losing patent protection. If that comes to pass, today's relatively low price will turn out to be a bargain.
#signal
There is nothing particularly unusual happening with Bristol Myers Squibb's business. That is important to highlight because the pharmaceutical industry is highly competitive, research-driven, and has a unique patent situation that materially complicates things even for the largest drug makers. The issue is that the patent protections for new drugs are time-limited, but research and development outcomes are unpredictable.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
That's the crux of the problem with Bristol Myers Squibb right now. Material patent expirations are occurring, including Revlimid and Pomalyst in 2026. And that will be followed by Eliquis, which is marketed with Pfizer (NYSE: PFE) in 2028. While patent expirations are common, the outcome is usually a material drop in revenue from the affected drugs. So Bristol Myers Squibb's top and bottom lines are going to be under pressure for a bit. If that's the case, the low P/E and high yield relative to the broader sector could simply be Wall Street pricing in the patent expirations.
Management isn't sitting around with its head in the sand. The company is actively looking for new drug candidates. And it actually has some attractive pipeline options in rare diseases, immunology, and cancer. If the company gets a couple of new blockbuster drugs approved, it could easily offset the hit from drugs that are losing patent protection. If that comes to pass, today's relatively low price will turn out to be a bargain.
#signal
20 hours ago
Photographs of the Prince and Princess of Wales with their children, Prince George, Princess Charlotte and Prince Louis, often look like they could have been taken for a Ralph Lauren catalogue. Whether on their Christmas card or at official occasions, the family exudes preppy glamour. So it felt entirely appropriate that three out of five members of the family sported clothing by the American label as they attended the Commonwealth Games in Glasgow on Saturday afternoon.
The Princess arrived to watch the netball semi-finals wearing an ensemble which might provide inspiration for anyone looking to master a smart-casual look this summer. The hero piece of the outfit was a new double-breasted blazer, the Camden cashmere design from Ralph Lauren Collection. According to the brand's website, the jacket "debuted as a men's sporting style in 19th-century Britain" and "is one of Ralph Lauren's enduring silhouettes". Notably, Ralph Lauren is the official outfitter of the Wimbledon Championships, where the Princess is royal patron.
While Catherine's forest green version isn't currently available to buy, the identical jacket in navy retails for £2,950 – a far cry from the Zara tailoring the Princess often wears. The rest of her look continued this upscale theme – she accessorised with diamond hoop earrings by Kiki McDonough, Gianvito Rossi shoes and an Anya Hindmarch handbag.
Catherine wore a Camden cashmere double-breasted blazer from Ralph Lauren and Gianvito Rossi shoes - Euan Cherry/Getty
Another key element of the Princess's outfit was a striped top, a design that she has become synonymous with ever since joining the Royal family. Catherine, who is known as the ******* ss of Rothesay in Scotland, has worn Breton tops for polo matches and relaxed family engagements as well as in difficult moments, such as the video she released telling the world she had cancer in 2023. The design also reflects the sporty Hamptons aesthetic of Ralph Lauren.
#princess #gianvito
The Princess arrived to watch the netball semi-finals wearing an ensemble which might provide inspiration for anyone looking to master a smart-casual look this summer. The hero piece of the outfit was a new double-breasted blazer, the Camden cashmere design from Ralph Lauren Collection. According to the brand's website, the jacket "debuted as a men's sporting style in 19th-century Britain" and "is one of Ralph Lauren's enduring silhouettes". Notably, Ralph Lauren is the official outfitter of the Wimbledon Championships, where the Princess is royal patron.
While Catherine's forest green version isn't currently available to buy, the identical jacket in navy retails for £2,950 – a far cry from the Zara tailoring the Princess often wears. The rest of her look continued this upscale theme – she accessorised with diamond hoop earrings by Kiki McDonough, Gianvito Rossi shoes and an Anya Hindmarch handbag.
Catherine wore a Camden cashmere double-breasted blazer from Ralph Lauren and Gianvito Rossi shoes - Euan Cherry/Getty
Another key element of the Princess's outfit was a striped top, a design that she has become synonymous with ever since joining the Royal family. Catherine, who is known as the ******* ss of Rothesay in Scotland, has worn Breton tops for polo matches and relaxed family engagements as well as in difficult moments, such as the video she released telling the world she had cancer in 2023. The design also reflects the sporty Hamptons aesthetic of Ralph Lauren.
#princess #gianvito
1 day ago
Scott McCarron got to ring the bell on Friday.
McCarron, 61, an 11-time PGA Tour Champions winner, rang the bell at Duke Medical Center in Durham, North Carolina, to signify that he is cancer free. Diagnosed March 23 with Diffused Large B cell Lymphoma, he had been undergoing daily radiation for the previous 10 days, making 5-hour roundtrips to his home.
"Thank you to all the doctors and nurses that took great care of me," he wrote in a social media post. "Thank you to all my friends, family and everyone that sent prayers my way. I'm forever grateful. Now back to golf!"
McCarron was diagnosed with Stage Two B-Cell lymphoma after coming down with a sore throat. Fortunately, he took it seriously because a doctor's visit led to a trip to an ear, nose and throat doctor, who suggested a biopsy.
"Most of us are pretty stubborn and don't do anything for a while," he told Golfweek. "As soon as the thing showed up, I said, 'I don't like the looks of it.'"
#throat #don 't #scott
McCarron, 61, an 11-time PGA Tour Champions winner, rang the bell at Duke Medical Center in Durham, North Carolina, to signify that he is cancer free. Diagnosed March 23 with Diffused Large B cell Lymphoma, he had been undergoing daily radiation for the previous 10 days, making 5-hour roundtrips to his home.
"Thank you to all the doctors and nurses that took great care of me," he wrote in a social media post. "Thank you to all my friends, family and everyone that sent prayers my way. I'm forever grateful. Now back to golf!"
McCarron was diagnosed with Stage Two B-Cell lymphoma after coming down with a sore throat. Fortunately, he took it seriously because a doctor's visit led to a trip to an ear, nose and throat doctor, who suggested a biopsy.
"Most of us are pretty stubborn and don't do anything for a while," he told Golfweek. "As soon as the thing showed up, I said, 'I don't like the looks of it.'"
#throat #don 't #scott
1 day ago
Sean Grayson, the officer who fatally shot Sonya Massey in her own home, has been denied medical release from his 20-year prison sentence. Grayson, a former Sangamon County sheriff's deputy, was diagnosed with Stage 3 colon cancer in 2023, his attorney, Mark Wykoff said at his sentencing in January.
#sean #sonya #sangamon #stage
#sean #sonya #sangamon #stage
1 day ago
The 47th Pan-Mass Challenge kicked off this weekend, bringing together 6,500 cyclists across Massachusetts for a two-day, 177-mile bike-a-thon to raise money for cancer research at Dana-Farber Cancer Institute.
Participants are aiming to raise $79 million, with 100% of every rider-raised dollar going directly to Dana-Farber for the 20th consecutive year.
PMC raised $78 million last year.
Riders began their journey Saturday morning from starting points in Worcester and Wellesley. The event features 14 one-and two-day routes across the state, ranging from 25 to 177 miles.
This is a developing story. Check back for updates as more information becomes available.
#dana #across #raise #mass
Participants are aiming to raise $79 million, with 100% of every rider-raised dollar going directly to Dana-Farber for the 20th consecutive year.
PMC raised $78 million last year.
Riders began their journey Saturday morning from starting points in Worcester and Wellesley. The event features 14 one-and two-day routes across the state, ranging from 25 to 177 miles.
This is a developing story. Check back for updates as more information becomes available.
#dana #across #raise #mass
2 days ago
CHICAGO (AP) — A former Illinois sheriff's deputy won't get an early medical release from his two-decade prison sentence for killing Sonya Massey inside her home after the Black woman called 911 about a possible prowler, state officials decided Friday.
Sean Grayson had been diagnosed with colon cancer prior to the 2024 shooting, and his attorney noted in January that the cancer had advanced to his liver and lungs.
The three-member Illinois Prisoner Review Board voted unanimously Friday to deny Grayson's application for early medical release, Liz Mitchell, a board spokesperson, said in an email.
Grayson, who is white, was convicted in October of second-degree murder for Massey's killing, a case that sparked protests over systemic racism and a U.S. Department of Justice review.
Body camera footage showed Grayson and another deputy enter Massey's home in Springfield, Illinois. Minutes later, Grayson shot the 36-year-old single mother in the face as she moved a pot of hot water from the stove and told him, "I rebuke you in the name of Jesus."
#board #deputy #release
Sean Grayson had been diagnosed with colon cancer prior to the 2024 shooting, and his attorney noted in January that the cancer had advanced to his liver and lungs.
The three-member Illinois Prisoner Review Board voted unanimously Friday to deny Grayson's application for early medical release, Liz Mitchell, a board spokesperson, said in an email.
Grayson, who is white, was convicted in October of second-degree murder for Massey's killing, a case that sparked protests over systemic racism and a U.S. Department of Justice review.
Body camera footage showed Grayson and another deputy enter Massey's home in Springfield, Illinois. Minutes later, Grayson shot the 36-year-old single mother in the face as she moved a pot of hot water from the stove and told him, "I rebuke you in the name of Jesus."
#board #deputy #release
2 days ago
Dwyane Wade: I definitely have a favorite championship and it's a no brainer. It's 2006. I love all my championships but that's my favorite because being a young kid at 24 years old. Everything just happened so fast in my life. 17 years old I'm like 'alright I'm putting everything into basketball' and then 24 winning a chip in the NBA. What? Being in the position where I was the leading man to accomplish that. My other championships I wasn't the leading guy. — that's the most proud I've ever been of myself.
YouTube
Dwyane Wade: "LeBron is never going to do what you think he's going to do. I don't think any of us had Philly pinned as the number one team, but it's right on brand. For me, when I look at that, it's a bigger than just a championship. The roster is incredible right now, and so he gets a chance to get to that maybe five, six championships. Outside of that, I look at that as an off-the-basketball move as well. I feel like it's bigger than just the two years." — 7/29/2026 YouTube
Dwyane Wade: "At 44 years old, I shouldn't have had cancer surgery already. I'm about the numbers, but it's scary in you. I started living a little different life, a little freer. I smile more, and I always smile. I laugh more. I appreciate more. I'm thankful. I feel better, feel younger. Well, not that left knee, but you know what I mean." — 7/26/2026 YouTube
#years #youtube #well
YouTube
Dwyane Wade: "LeBron is never going to do what you think he's going to do. I don't think any of us had Philly pinned as the number one team, but it's right on brand. For me, when I look at that, it's a bigger than just a championship. The roster is incredible right now, and so he gets a chance to get to that maybe five, six championships. Outside of that, I look at that as an off-the-basketball move as well. I feel like it's bigger than just the two years." — 7/29/2026 YouTube
Dwyane Wade: "At 44 years old, I shouldn't have had cancer surgery already. I'm about the numbers, but it's scary in you. I started living a little different life, a little freer. I smile more, and I always smile. I laugh more. I appreciate more. I'm thankful. I feel better, feel younger. Well, not that left knee, but you know what I mean." — 7/26/2026 YouTube
#years #youtube #well
2 days ago
Kate Middleton has grown into one of the most popular members of the royal family. According to one royal expert, she is the monarchy's "greatest ****** et." Experts believe King Charles III and Kate now share a stronger relationship following their cancer diagnoses.
Royal expert Katie Nicholl, who serves as Vanity Fair's royal correspondent and co-hosts The Royals Uncensored, said, "I think Catherine, the Princess of Wales, has always been a very valuable ****** et to the royal family."
"She is the commoner who married into the royal family … [She has made] a seamless transition into that unique world of royalty. It's not easy … There's a huge amount of sacrifice that goes into being a member of the royal family," the expert told Fox News.
Nicholl said Catherine has made many personal sacrifices but has handled them with grace, dignity, and a smile. She added that both Charles and Queen Camilla deeply admire Catherine. Buckingham Palace announced the King's diagnosis in 2024. In December 2025, Charles shared that his treatment would be reduced in 2026.
On the other hand, the mother of three shared in September 2024 that she had finished chemotherapy and considered herself "cancer-free." She later announced in January 2025 that she was in remission. British broadcaster Helena Chard noted that King Charles, 77, has been greatly inspired by Kate's strength.
#family
Royal expert Katie Nicholl, who serves as Vanity Fair's royal correspondent and co-hosts The Royals Uncensored, said, "I think Catherine, the Princess of Wales, has always been a very valuable ****** et to the royal family."
"She is the commoner who married into the royal family … [She has made] a seamless transition into that unique world of royalty. It's not easy … There's a huge amount of sacrifice that goes into being a member of the royal family," the expert told Fox News.
Nicholl said Catherine has made many personal sacrifices but has handled them with grace, dignity, and a smile. She added that both Charles and Queen Camilla deeply admire Catherine. Buckingham Palace announced the King's diagnosis in 2024. In December 2025, Charles shared that his treatment would be reduced in 2026.
On the other hand, the mother of three shared in September 2024 that she had finished chemotherapy and considered herself "cancer-free." She later announced in January 2025 that she was in remission. British broadcaster Helena Chard noted that King Charles, 77, has been greatly inspired by Kate's strength.
#family
3 days ago
The Atlanta Falcons have announced the death of defensive coordinator Jeff Ulbrich's wife.
Cristina Ulbrich lost her "courageous battle with cancer," the organization announced on Thursday.
Comments from Falcons fans across the country poured in for the Ulbrich family.
[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]
"Cristina was a devoted wife, mother, and friend whose strength, grace, and resilience touched all who knew her. She was a constant source of love and support to Jeff, their family, and the broader Falcons community," they wrote in a statement.
#comments
Cristina Ulbrich lost her "courageous battle with cancer," the organization announced on Thursday.
Comments from Falcons fans across the country poured in for the Ulbrich family.
[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]
"Cristina was a devoted wife, mother, and friend whose strength, grace, and resilience touched all who knew her. She was a constant source of love and support to Jeff, their family, and the broader Falcons community," they wrote in a statement.
#comments
3 days ago
The Atlanta Falcons have announced the death of defensive coordinator Jeff Ulbrich's wife.
Cristina Ulbrich lost her "courageous battle with cancer," the organization announced on Thursday.
Comments from Falcons fans across the country poured in for the Ulbrich family.
[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]
"Cristina was a devoted wife, mother, and friend whose strength, grace, and resilience touched all who knew her. She was a constant source of love and support to Jeff, their family, and the broader Falcons community," they wrote in a statement.
#ulbrich
Cristina Ulbrich lost her "courageous battle with cancer," the organization announced on Thursday.
Comments from Falcons fans across the country poured in for the Ulbrich family.
[DOWNLOAD: Free WSB-TV News app for alerts as news breaks]
"Cristina was a devoted wife, mother, and friend whose strength, grace, and resilience touched all who knew her. She was a constant source of love and support to Jeff, their family, and the broader Falcons community," they wrote in a statement.
#ulbrich
3 days ago
By Dietrich Knauth
NEW YORK, July 29 (Reuters) - After years of failed attempts to resolve thousands of lawsuits alleging that its talc products caused cancer, Johnson & Johnson says it has reached a settlement, worth at least $5.5 billion, that could finally help bring an end to litigation that has dogged the company for over a decade.
WHAT IS THE TALC LITIGATION ABOUT?
Tens of thousands of people have sued J&J in federal and state courts, alleging that its talc-based baby powder and other products caused ovarian cancer.
J&J has long denied the allegations, arguing that decades of scientific testing show its talc products are safe and do not cause cancer.
#thousands #alleging #caused
NEW YORK, July 29 (Reuters) - After years of failed attempts to resolve thousands of lawsuits alleging that its talc products caused cancer, Johnson & Johnson says it has reached a settlement, worth at least $5.5 billion, that could finally help bring an end to litigation that has dogged the company for over a decade.
WHAT IS THE TALC LITIGATION ABOUT?
Tens of thousands of people have sued J&J in federal and state courts, alleging that its talc-based baby powder and other products caused ovarian cancer.
J&J has long denied the allegations, arguing that decades of scientific testing show its talc products are safe and do not cause cancer.
#thousands #alleging #caused
3 days ago
TV presenter and Newcastle United fan Declan Donnelly has paid an emotional tribute to his "childhood hero" Kevin Keegan following the football legend's death aged 75.
Keegan, a revered figure who managed Newcastle United and also played for the club for two years, passed away on 20 July after a battle with stage four cancer.
Donnelly, alongside his presenting partner Anthony McPartlin, honoured Keegan on their podcast, Hanging Out With Ant And Dec.
The duo hailed him as a "true legend to Newcastle United supporters," reflecting on his profound impact.
They opened the episode by acknowledging Keegan's immense significance to the people of the North East.
#hanging
Keegan, a revered figure who managed Newcastle United and also played for the club for two years, passed away on 20 July after a battle with stage four cancer.
Donnelly, alongside his presenting partner Anthony McPartlin, honoured Keegan on their podcast, Hanging Out With Ant And Dec.
The duo hailed him as a "true legend to Newcastle United supporters," reflecting on his profound impact.
They opened the episode by acknowledging Keegan's immense significance to the people of the North East.
#hanging
3 days ago
Real Housewives of Orange County alum Jeana Keough is nearing the end of her tongue cancer treatment, but she's making clear the fight is far from over.
According to a report Page Six published Thursday, July 30, Keough, 70, discussed her prognosis via email, writing, "It's upsetting to know that even after all this treatment, I still only have a 40 to 60 percent cure rate within the next five years. We're just praying that I'm on the good side of that coin flip."
She continued, "I can see the finish line now, but I'm hearing it's a long climb to recovery and that I'll likely have the feeding tube for two to six months."
Instagram / karakeoughboz
Keough also revealed that her diagnosis was delayed after what she described as a misdiagnosis by her longtime dentist. She stated that she initially sought treatment for a sore on her tongue, but her dentist believed one of her teeth was rubbing against it and repeatedly filed the tooth down over several visits rather than referring her to a specialist or recommending a biopsy.
#treatment #orange
According to a report Page Six published Thursday, July 30, Keough, 70, discussed her prognosis via email, writing, "It's upsetting to know that even after all this treatment, I still only have a 40 to 60 percent cure rate within the next five years. We're just praying that I'm on the good side of that coin flip."
She continued, "I can see the finish line now, but I'm hearing it's a long climb to recovery and that I'll likely have the feeding tube for two to six months."
Instagram / karakeoughboz
Keough also revealed that her diagnosis was delayed after what she described as a misdiagnosis by her longtime dentist. She stated that she initially sought treatment for a sore on her tongue, but her dentist believed one of her teeth was rubbing against it and repeatedly filed the tooth down over several visits rather than referring her to a specialist or recommending a biopsy.
#treatment #orange
3 days ago
Kate Middleton's resilience continues to inspire those closest to her. Just weeks after the Princess of Wales completed one of the United Kingdom's toughest endurance challenges as part of her cancer recovery journey, her maternal uncle, Gary Goldsmith, has publicly praised her determination while revealing a deeply personal health crisis that nearly claimed his own life.
You may also like
Princess Beatrice visits one of Queen Elizabeth II's favorite London stores in chic summer look ahead of her 38th birthday
Why King Charles keeps wearing Princess Charlotte's handmade bracelet to major royal events
What Kate Middleton's cancer journey teaches us about life after cancer
#journey #wales #gary #goldsmith
You may also like
Princess Beatrice visits one of Queen Elizabeth II's favorite London stores in chic summer look ahead of her 38th birthday
Why King Charles keeps wearing Princess Charlotte's handmade bracelet to major royal events
What Kate Middleton's cancer journey teaches us about life after cancer
#journey #wales #gary #goldsmith
4 days ago
Hey Creatorverse readers,
Amid all the chatter about brand deals and follower counts, the charitable side of creators is often overlooked. This past week, two major creators — MrBeast (510 million YouTube subscribers) and Jacksepticeye (31 million subscribers) — doubled down on giving back.
Though MrBeast and Jacksepticeye are the two creators making headlines right now, philanthropic efforts are baked into the work of many creators, partially because giveaways and community alignment are so core to the creator ecosystem. That focus has translated into an increase in donations from Millennial and Gen Z audiences as donations overall have declined.
MrBeast partnered with Disney and Stand Up to Cancer (SU2C) on "I Granted 100 Kids Their Biggest Wish!" a video that chronicled celebrities like MrBeast, Dwayne Johnson and LeBron James granting some of the biggest dreams to children who have been diagnosed with cancer. The goal of the video is to increase awareness for pediatric cancer and raise funds for research, which naturally includes an elaborate MrBeast giveaway for anyone who donates to the charity Give Kids The World. Since being posted on Sunday, the video has accumulated over 30 million views. Those views will only increase as the video remains on MrBeast's channel for the next six months.
"We've never had an opportunity like this to engage people all over the world, and certainly not through a creator platform at this scale. So, it's truly a 'first' for SU2C," Pam Williams, a member of the SU2C founders and advisors committee, told me. So far it's a strategy that's working. The video has been seen by people in 68 countries so far, and almost 90% of donators are supporting the organization for the first time.
#creators
Amid all the chatter about brand deals and follower counts, the charitable side of creators is often overlooked. This past week, two major creators — MrBeast (510 million YouTube subscribers) and Jacksepticeye (31 million subscribers) — doubled down on giving back.
Though MrBeast and Jacksepticeye are the two creators making headlines right now, philanthropic efforts are baked into the work of many creators, partially because giveaways and community alignment are so core to the creator ecosystem. That focus has translated into an increase in donations from Millennial and Gen Z audiences as donations overall have declined.
MrBeast partnered with Disney and Stand Up to Cancer (SU2C) on "I Granted 100 Kids Their Biggest Wish!" a video that chronicled celebrities like MrBeast, Dwayne Johnson and LeBron James granting some of the biggest dreams to children who have been diagnosed with cancer. The goal of the video is to increase awareness for pediatric cancer and raise funds for research, which naturally includes an elaborate MrBeast giveaway for anyone who donates to the charity Give Kids The World. Since being posted on Sunday, the video has accumulated over 30 million views. Those views will only increase as the video remains on MrBeast's channel for the next six months.
"We've never had an opportunity like this to engage people all over the world, and certainly not through a creator platform at this scale. So, it's truly a 'first' for SU2C," Pam Williams, a member of the SU2C founders and advisors committee, told me. So far it's a strategy that's working. The video has been seen by people in 68 countries so far, and almost 90% of donators are supporting the organization for the first time.
#creators
4 days ago
Nicole "Snooki" Polizzi is giving fans a look at her preparations for her upcoming hysterectomy amid her battle with cervical cancer.
The Jersey Shore: Family Vacation star, 38, took to TikTok on Tuesday, July 28, to share the must-have items she's purchased in preparation for her surgery.
The products for the procedure, which Polizzi said is happening "soon," include several fan-recommended buys, like an abdominal band to support her midsection, constipation aids and a weighted heating pad.
In another video, Polizzi shared that she also purchased a few loose-fitting nightgowns, as well as oversized underwear to keep the area around her incision comfortable.
"You guys know I don't like pain, and I want to be cozy and comfy, and I needed recommendations on how to, like, recover the best way after my hysterectomy," Polizzii said. "If I'm missing anything, mamas, anybody who has gotten a hysterectomy with the big cut, please help. I don't want to feel pain. If you know me, I'm a baby. I don't like pain. I don't like any type of uncomfortableness, and yeah, I just, I don't like it. So obviously, I'll have, like, some pain meds and stuff."
#don 't #polizzi #purchased
The Jersey Shore: Family Vacation star, 38, took to TikTok on Tuesday, July 28, to share the must-have items she's purchased in preparation for her surgery.
The products for the procedure, which Polizzi said is happening "soon," include several fan-recommended buys, like an abdominal band to support her midsection, constipation aids and a weighted heating pad.
In another video, Polizzi shared that she also purchased a few loose-fitting nightgowns, as well as oversized underwear to keep the area around her incision comfortable.
"You guys know I don't like pain, and I want to be cozy and comfy, and I needed recommendations on how to, like, recover the best way after my hysterectomy," Polizzii said. "If I'm missing anything, mamas, anybody who has gotten a hysterectomy with the big cut, please help. I don't want to feel pain. If you know me, I'm a baby. I don't like pain. I don't like any type of uncomfortableness, and yeah, I just, I don't like it. So obviously, I'll have, like, some pain meds and stuff."
#don 't #polizzi #purchased
4 days ago
By Dietrich Knauth
NEW YORK, July 29 (Reuters) - After years of failed attempts to resolve thousands of lawsuits alleging that its talc products caused cancer, Johnson & Johnson says it has reached a settlement, worth at least $5.5 billion, that could finally help bring an end to litigation that has dogged the company for over a decade.
WHAT IS THE TALC LITIGATION ABOUT?
Tens of thousands of people have sued J&J in federal and state courts, alleging that its talc-based baby powder and other products caused ovarian cancer.
J&J has long denied the allegations, arguing that decades of scientific testing show its talc products are safe and do not cause cancer.
#caused #dietrich
NEW YORK, July 29 (Reuters) - After years of failed attempts to resolve thousands of lawsuits alleging that its talc products caused cancer, Johnson & Johnson says it has reached a settlement, worth at least $5.5 billion, that could finally help bring an end to litigation that has dogged the company for over a decade.
WHAT IS THE TALC LITIGATION ABOUT?
Tens of thousands of people have sued J&J in federal and state courts, alleging that its talc-based baby powder and other products caused ovarian cancer.
J&J has long denied the allegations, arguing that decades of scientific testing show its talc products are safe and do not cause cancer.
#caused #dietrich
5 days ago
Former Real Housewives of Orange County star Jeana Keough was diagnosed with squamous cell carcinoma of the tongue, her daughter Kara and son Shane revealed on July 19
As a result of her chemotherapy and radiation, she has suffered severe pain, malnutrition and a blood clot
Her daughter announced on Monday, July 27, that due to the pain and treatment, her mother can't speak
Jeana Keough continues to face difficult challenges amid her tongue cancer treatment.
The two older children of the Real Housewives of Orange County alum, 70, Kara, 37, and Shane, 39, revealed on July 19 that their mother was diagnosed with squamous cell carcinoma of the tongue after she noticed a painful spot on her tongue and decided to get a biopsy. (Jeana also shares 34-year-old son Colton with her late husband, Matt Keough.)
#county
As a result of her chemotherapy and radiation, she has suffered severe pain, malnutrition and a blood clot
Her daughter announced on Monday, July 27, that due to the pain and treatment, her mother can't speak
Jeana Keough continues to face difficult challenges amid her tongue cancer treatment.
The two older children of the Real Housewives of Orange County alum, 70, Kara, 37, and Shane, 39, revealed on July 19 that their mother was diagnosed with squamous cell carcinoma of the tongue after she noticed a painful spot on her tongue and decided to get a biopsy. (Jeana also shares 34-year-old son Colton with her late husband, Matt Keough.)
#county
5 days ago
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter.
Sarepta Therapeutics has found the leader it hopes can engineer a desperately needed turnaround.
The company on Monday announced that Michael Severino, an executive with leadership experience at startups as well as large drugmakers, will become its next CEO effective July 28. He'll replace longtime leader Doug Ingram, who in February announced plans to retire after a tumultuous run.
Severino has been working in the biopharmaceutical industry for more than two decades, including stops at AbbVie and Amgen. At AbbVie, Severino helped bring to market multiple drugs for psoriasis, arthritis, cancer and hepatitis C. At Amgen, he oversaw research and development as the company's senior vice president of development and corporate chief medical officer.
In 2022, Severino left AbbVie to run Tessera Therapeutics, a buzzy "gene writing" startup backed by Flagship Pioneering. Tessera recently brought its first drug prospect, a gene editing treatment for alpha-1 antitrypsin deficiency, into clinical testing. Last week, Tessera announced that Severino had joined a "commercial stage" biotech company and that former Merck & Co. executive Joseph Romanelli would serve as its next leader.
#abbvie #tessera #biopharma #amgen
Sarepta Therapeutics has found the leader it hopes can engineer a desperately needed turnaround.
The company on Monday announced that Michael Severino, an executive with leadership experience at startups as well as large drugmakers, will become its next CEO effective July 28. He'll replace longtime leader Doug Ingram, who in February announced plans to retire after a tumultuous run.
Severino has been working in the biopharmaceutical industry for more than two decades, including stops at AbbVie and Amgen. At AbbVie, Severino helped bring to market multiple drugs for psoriasis, arthritis, cancer and hepatitis C. At Amgen, he oversaw research and development as the company's senior vice president of development and corporate chief medical officer.
In 2022, Severino left AbbVie to run Tessera Therapeutics, a buzzy "gene writing" startup backed by Flagship Pioneering. Tessera recently brought its first drug prospect, a gene editing treatment for alpha-1 antitrypsin deficiency, into clinical testing. Last week, Tessera announced that Severino had joined a "commercial stage" biotech company and that former Merck & Co. executive Joseph Romanelli would serve as its next leader.
#abbvie #tessera #biopharma #amgen
5 days ago
Actor James Woods said he is worried the recent "Muslim invasion" of the USA will be the point where historians look back and say the country took a nosedive into ****** .
He shared his concern about the rise of Islam during a Monday interview on right-wing pundit Benny Johnson's show.
Woods — one of the few outspoken conservatives in Hollywood — said he believed the election of democratic socialist and Muslim Zohran Mamdani (D) as New York City's mayor was "the most dangerous event" in modern American history. He said it signaled the downfall of the nation.
"Look, I think America is the greatest human endeavor in the history of humankind. I think it's in terrible trouble. I mean, the city where the World Trade Center and the people in it were slaughtered and destroyed, how you could ever allow this Muslim invasion and cancer?" Woods asked.
"And they say, 'What are you, prejudiced?' Well, yes. I'm sorry to say it," he continued.
#look #history #james
He shared his concern about the rise of Islam during a Monday interview on right-wing pundit Benny Johnson's show.
Woods — one of the few outspoken conservatives in Hollywood — said he believed the election of democratic socialist and Muslim Zohran Mamdani (D) as New York City's mayor was "the most dangerous event" in modern American history. He said it signaled the downfall of the nation.
"Look, I think America is the greatest human endeavor in the history of humankind. I think it's in terrible trouble. I mean, the city where the World Trade Center and the people in it were slaughtered and destroyed, how you could ever allow this Muslim invasion and cancer?" Woods asked.
"And they say, 'What are you, prejudiced?' Well, yes. I'm sorry to say it," he continued.
#look #history #james
5 days ago
Amy Dowden has credited her best friend and fellow Strictly Come Dancing professional Carlos Gu with convincing her not to "hang up her dancing shoes" following her cancer treatment.
The 35-year-old told The Mirror she was at an "ultimate low" after being forced to quit the show in 2024 because of illness.
The Welsh dancer said she was able to regain her confidence after receiving some "tough love" and "motivation" from Gu and her husband Ben Jones.
Dowden and Gu participate in the latest series of Celebrity Hunted in which pairs go on the run as they are pursued by an elite team of hunters.
Strictly's Amy Dowden unsure 'if I'm able to be a mum' after cancer
#able #strictly #come #jones
The 35-year-old told The Mirror she was at an "ultimate low" after being forced to quit the show in 2024 because of illness.
The Welsh dancer said she was able to regain her confidence after receiving some "tough love" and "motivation" from Gu and her husband Ben Jones.
Dowden and Gu participate in the latest series of Celebrity Hunted in which pairs go on the run as they are pursued by an elite team of hunters.
Strictly's Amy Dowden unsure 'if I'm able to be a mum' after cancer
#able #strictly #come #jones
6 days ago
A brain cancer diagnosis could have ended Archie Goodburn's career. Instead, it became the beginning of a story that captivated the Commonwealth Games. He didn't need a medal to win over the crowd. All he had to do was step onto the blocks.
Just two years after being diagnosed with an incurable form of brain cancer, the Scottish swimmer continues to fight battles far beyond the pool. The 25-year-old swimmer, who won the 2023 British Swimming Championships, broke down in tears after finishing seventh in the men's 50m ***** troke final at the 2026 Commonwealth Games.
"Outside the pool I dream of a future where brain cancer isn't the biggest killer of those under 40, where the UK government establishes a brain cancer lead to make that change," he said. "I'd much prefer that change is made, and that dream is completed, than any of my personal goals in the pool because what families and young people are going through out there is really beyond the comprehension of many people out there and certainly harder than anything I've had to do as a world-class sportsman."
If we take a look at his journey, the path for him has been anything but ordinary.
In 2024, Goodburn's Olympic dream took a devastating turn. After weeks of experiencing seizures, numbness down his left side and recurring feelings of déjà vu, the then-22-year-old received a phone call after training that changed everything.
#dream
Just two years after being diagnosed with an incurable form of brain cancer, the Scottish swimmer continues to fight battles far beyond the pool. The 25-year-old swimmer, who won the 2023 British Swimming Championships, broke down in tears after finishing seventh in the men's 50m ***** troke final at the 2026 Commonwealth Games.
"Outside the pool I dream of a future where brain cancer isn't the biggest killer of those under 40, where the UK government establishes a brain cancer lead to make that change," he said. "I'd much prefer that change is made, and that dream is completed, than any of my personal goals in the pool because what families and young people are going through out there is really beyond the comprehension of many people out there and certainly harder than anything I've had to do as a world-class sportsman."
If we take a look at his journey, the path for him has been anything but ordinary.
In 2024, Goodburn's Olympic dream took a devastating turn. After weeks of experiencing seizures, numbness down his left side and recurring feelings of déjà vu, the then-22-year-old received a phone call after training that changed everything.
#dream
8 days ago
William Shatner plans to boldly go where few have gone before, reveals a source, becoming a supercentenarian with the help of the latest in science advances!
"He genuinely believes he can make it to at least 110 if he keeps looking after himself and stays mentally engaged," dishes the source. "He's immersed in learning about all the possibilities, spending hours reading, listening to experts and following breakthroughs. William seems convinced we're living through a period where people will be able to extend their lives longer than ever."
According to the source, the Star Trek legend, 95, appears especially invigorated after "being pulled back from the brink" during his stage 4 cancer battle.
Now in remission, Shatner — who was diagnosed back in 2023 — required surgery and two years of immunotherapy to eradicate the malignant melanoma that had spread to his lungs and brain, per People.
"He's feeling absolutely fantastic these days and has confidence that he's still got decades ahead of him," shares our source. "He's got far too many things left on his bucket list to start thinking about slowing down."
#source #shatner #star #trek
"He genuinely believes he can make it to at least 110 if he keeps looking after himself and stays mentally engaged," dishes the source. "He's immersed in learning about all the possibilities, spending hours reading, listening to experts and following breakthroughs. William seems convinced we're living through a period where people will be able to extend their lives longer than ever."
According to the source, the Star Trek legend, 95, appears especially invigorated after "being pulled back from the brink" during his stage 4 cancer battle.
Now in remission, Shatner — who was diagnosed back in 2023 — required surgery and two years of immunotherapy to eradicate the malignant melanoma that had spread to his lungs and brain, per People.
"He's feeling absolutely fantastic these days and has confidence that he's still got decades ahead of him," shares our source. "He's got far too many things left on his bucket list to start thinking about slowing down."
#source #shatner #star #trek
9 days ago
Liverpool's first pre-season outing of the summer was already going to carry curiosity, because a new head coach always brings questions, fresh ideas and a sense of reset. Yet Saturday's meeting with Sunderland now carries something far more important. As reported by BBC Sport, both clubs will honour Kevin Keegan with black armbands and a minute's applause before kick-off.
That feels fitting. Keegan belonged to an era when footballers seemed larger than life, full of energy, swagger and personality, and he left a mark on every club lucky enough to call him their own. He died this week at the age of 75, months after it was announced that he had been diagnosed with stage four cancer. For many supporters, particularly those of a certain vintage, the news landed with real force.
At Liverpool, Keegan was central to one of the club's great periods of growth. Nearly 750 club appearances came across his wider career, but the six years on Merseyside remain a huge part of why he is remembered with such affection. Three league ****** les, the European Cup, two UEFA Cups and the FA Cup tell their own story. So do the Ballon d'Or wins in 1978 and 1979, achieved while he was with Hamburg, proof that his standing stretched well beyond English football.
He was a footballer who played with urgency and emotion, and those are qualities supporters always respond to. Trophies matter, of course, but connection matters too. Keegan had both.
This match also opens the Andoni Iraola chapter. After the collapse of last season and the end of Arne Slot's reign in May, Liverpool head into 2026-27 needing clarity and momentum. Iraola's first game arrives with notable absentees after Mohamed Salah, Andy Robertson and Ibrahima Konate departed at the end of last term.
#keegan #head #always #club
That feels fitting. Keegan belonged to an era when footballers seemed larger than life, full of energy, swagger and personality, and he left a mark on every club lucky enough to call him their own. He died this week at the age of 75, months after it was announced that he had been diagnosed with stage four cancer. For many supporters, particularly those of a certain vintage, the news landed with real force.
At Liverpool, Keegan was central to one of the club's great periods of growth. Nearly 750 club appearances came across his wider career, but the six years on Merseyside remain a huge part of why he is remembered with such affection. Three league ****** les, the European Cup, two UEFA Cups and the FA Cup tell their own story. So do the Ballon d'Or wins in 1978 and 1979, achieved while he was with Hamburg, proof that his standing stretched well beyond English football.
He was a footballer who played with urgency and emotion, and those are qualities supporters always respond to. Trophies matter, of course, but connection matters too. Keegan had both.
This match also opens the Andoni Iraola chapter. After the collapse of last season and the end of Arne Slot's reign in May, Liverpool head into 2026-27 needing clarity and momentum. Iraola's first game arrives with notable absentees after Mohamed Salah, Andy Robertson and Ibrahima Konate departed at the end of last term.
#keegan #head #always #club
9 days ago
We can separate high-yield dividend stocks into two broad categories. The first group consists of companies with stable businesses that generate consistent cash flow and are very likely to continue paying -- and perhaps raising -- their dividends for the foreseeable future. The second are distressed corporations. They boast high yields because their share prices have fallen substantially, reflecting weak business fundamentals.
Many investors would put Pfizer (NYSE: PFE) in the second group. The drugmaker's shares have lost significant value over the past five years, as the company has failed to sustain the amazing success it achieved in the coronavirus market. However, there is much more to the story. Let's discuss why Pfizer's 7% forward yield is more sustainable than it appears at first glance.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Pfizer's revenue and earnings have declined over the past five years, while it has maintained and even increased its dividend. The company's payout ratio has soared as a result -- it is currently about 127%. That looks unsustainable. But Pfizer's cash payout ratio, a much better measure of whether the company can maintain its dividend program intact, looks less scary at 107.7%. Management is confident of the company's ability to sustain, and even increase, the payout moving forward. That isn't just wishful thinking: Pfizer could improve its business in the coming years and eventually post much stronger financial results.
Consider that Pfizer boasts highly promising programs in the pipeline that will yield brand-new approvals and label expansions. For instance, the company's Padcev is a cancer medicine that is currently one of its better-performing products. On July 10, Padcev earned approval for the treatment of muscle-invasive bladder cancer in combination with Merck's (NYSE: MRK) Keytruda. Padcev was granted the green light regardless of whether patients are eligible for Cisplatin, a chemotherapy drug for bladder cancer that is effective but comes with significant side effects. That's a big deal since many drugs for bladder cancer (including Padcev, initially) aren't approved regardless of Cisplatin eligibility.
#NVIDIA #yield #first
Many investors would put Pfizer (NYSE: PFE) in the second group. The drugmaker's shares have lost significant value over the past five years, as the company has failed to sustain the amazing success it achieved in the coronavirus market. However, there is much more to the story. Let's discuss why Pfizer's 7% forward yield is more sustainable than it appears at first glance.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Pfizer's revenue and earnings have declined over the past five years, while it has maintained and even increased its dividend. The company's payout ratio has soared as a result -- it is currently about 127%. That looks unsustainable. But Pfizer's cash payout ratio, a much better measure of whether the company can maintain its dividend program intact, looks less scary at 107.7%. Management is confident of the company's ability to sustain, and even increase, the payout moving forward. That isn't just wishful thinking: Pfizer could improve its business in the coming years and eventually post much stronger financial results.
Consider that Pfizer boasts highly promising programs in the pipeline that will yield brand-new approvals and label expansions. For instance, the company's Padcev is a cancer medicine that is currently one of its better-performing products. On July 10, Padcev earned approval for the treatment of muscle-invasive bladder cancer in combination with Merck's (NYSE: MRK) Keytruda. Padcev was granted the green light regardless of whether patients are eligible for Cisplatin, a chemotherapy drug for bladder cancer that is effective but comes with significant side effects. That's a big deal since many drugs for bladder cancer (including Padcev, initially) aren't approved regardless of Cisplatin eligibility.
#NVIDIA #yield #first
9 days ago
Novocure delivered record quarterly revenue and active patient growth, raised its full-year financial guidance and expanded the commercial reach of Optune Pax with European approval.
Novocure (NASDAQ:NVCR) reported record second-quarter net revenue of $183.6 million, up 16% year over year.
Global active patients receiving TTFields therapy increased 18% to 5,128 across all indications.
The company raised its 2026 revenue guidance to $710 million-$725 million and improved its adjusted EBITDA outlook.
Optune Pax received CE Mark approval for locally advanced pancreatic cancer, with Germany becoming the first European launch market.
#year #million #record #raised
Novocure (NASDAQ:NVCR) reported record second-quarter net revenue of $183.6 million, up 16% year over year.
Global active patients receiving TTFields therapy increased 18% to 5,128 across all indications.
The company raised its 2026 revenue guidance to $710 million-$725 million and improved its adjusted EBITDA outlook.
Optune Pax received CE Mark approval for locally advanced pancreatic cancer, with Germany becoming the first European launch market.
#year #million #record #raised
10 days ago
Finding a good dividend stock to buy at any given time usually isn't too tough. Finding one you can buy and hold forever, however, is a different story. The matter of longevity comes into play. You want to be sure the underlying company has the longevity required to not only continue paying its dividend, but to reliably raise its dividend payments at least in step with inflation. That's a taller order.
Nevertheless, these dividend names are out there. Here's a closer look at three of them.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Given the company's struggle since the easing of the COVID-19 pandemic undermined a fantastic but short-lived franchise, some investors might be surprised that drugmaker Pfizer (NYSE: PFE) earned a spot on this list. But it has, particularly since newcomers will be plugging into a healthy forward-looking dividend yield of 6.9%.
Although it'll be a while until investors can clearly see it, this pharmaceutical giant is developing multiple new profit centers. It acquired Seagen in 2023, for instance, largely for its oncology pipeline. This pipeline includes cancer-fighting Padcev, which was recently approved as a treatment for muscle-invasive bladder cancer when used in conjunction with Merck's Keytruda.
#Dividend #flashing
Nevertheless, these dividend names are out there. Here's a closer look at three of them.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Given the company's struggle since the easing of the COVID-19 pandemic undermined a fantastic but short-lived franchise, some investors might be surprised that drugmaker Pfizer (NYSE: PFE) earned a spot on this list. But it has, particularly since newcomers will be plugging into a healthy forward-looking dividend yield of 6.9%.
Although it'll be a while until investors can clearly see it, this pharmaceutical giant is developing multiple new profit centers. It acquired Seagen in 2023, for instance, largely for its oncology pipeline. This pipeline includes cancer-fighting Padcev, which was recently approved as a treatment for muscle-invasive bladder cancer when used in conjunction with Merck's Keytruda.
#Dividend #flashing
